Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA
Research output: Contribution to journal › Journal article › Research
All HIV/hepatitis C virus (HCV)-coinfected patients with chronic HCV infection and ≥ F2 fibrosis should be considered for HCV therapy. This study aimed to determine the rate of HCV treatment uptake among coinfected patients in Europe.
Original language | English |
---|---|
Journal | HIV Medicine |
Volume | 14 |
Issue number | 10 |
Pages (from-to) | 614-23 |
Number of pages | 10 |
ISSN | 1464-2662 |
DOIs | |
Publication status | Published - Nov 2013 |
ID: 93934717